Previous study 31 reported that C5aR antagonist attenuated placental ischaemia‐induced hypertension and followed endothelial dysfunction in rat reduced uterine perfusion pressure (RUPP) model, but the mechanism was still unknown. This evidence concerns the gene C5AR1 and hypertensive disorder.